Zdrowie i gospodarka · 18/11/2016

FDA Releases Revised Guidance on Donor Eligibility for Human Cells, Tissues, and Products

The Food and Drug Administration (FDA) has announced the availability of a revised guidance document that updates recommendations for determining the eligibility of donors of human cells, tissues, and products who have received human-derived clotting factor concentrates. The new guidance clarifies that receipt of FDA-licensed HDCFCs is no longer considered a risk factor for HIV, HBV, or HCV when determining donor eligibility.